亲环素A在肿瘤中的作用机制

doi:10.3760/cma.j.issn.1673-422X.2016.06.010

国际肿瘤学杂志 ›› 2016, Vol. 43 ›› Issue (6): 439-441.doi: 10.3760/cma.j.issn.1673-422X.2016.06.010

亲环素A在肿瘤中的作用机制

陆凯强，周志刚，田雯，邹志楠，廖彩勤，谢飞燕，涂剑

421001 衡阳，南华大学药物药理研究所（陆凯强、田雯、邹志楠、廖彩勤、谢飞燕、涂剑）；南华大学附属第一医院麻醉科（周志刚）

收稿日期:2016-01-11 出版日期:2016-06-08 发布日期:2016-04-27
通讯作者: 涂剑 E-mail:tujian0734@aliyun.com
基金资助:
国家自然科学基金（81541163）；湖南省自然科学基金（2015JJ3101）；湖南省教育厅创新平台开放基金（15K111）；南华大学博士启动基金（2011XQD44）；“湖南省分子靶标新药研究协同创新中心”培育项目（2014，405）

Mechanism of Cyclophilin A in tumor

Lu Kaiqiang, Zhou Zhigang, Tian Wen, Zou Zhinan, Liao Caiqin, Xie Feiyan, Tu Jian

Institute of Pharmacy & Pharmacology, University of South China, Hengyang 421001, China

Received:2016-01-11 Online:2016-06-08 Published:2016-04-27
Contact: Tu Jian E-mail:tujian0734@aliyun.com
Supported by:
National Natural Science Foundation of China (81541163); Natural Science Foundation of Hunan Province (2015JJ3101); Open Fund Based on Innovation Platform of Hunan Provincial Education Department (15K111); Scientific Research Foundation for Doctors in University of South China (2011XQD44); Hunan Provincial Cooperative Innovation Center for Molecular Target New Drug Study (2014，405)

摘要/Abstract

摘要： 亲环素A在多种肿瘤细胞中高表达，可通过诱导炎癌转化，加快肿瘤细胞转录周期，促进肿瘤细胞侵袭转移，抑制肿瘤细胞凋亡，以及降低肿瘤细胞对化疗药物的敏感性等多种途径调控多种肿瘤的发生发展，提示亲环素A可能是一种促癌基因，有望成为肿瘤治疗新靶标。

关键词: 肿瘤, 亲环素A, 药理作用分子作用机制

Abstract: Cyclophilin A (CypA) is found to be highly expressed in different kinds of tumor cells, which could regulate the occurrence and development of many kinds of tumor through multiple signal transduction pathways such as inducing the formation of inflammatory carcinoma, accelerating the transcription cycle of tumor cells, promoting the invasion and metastasis of tumor cells, inhibiting the apoptosis of tumor cells and reducing the sensitivity of tumor cells to chemotherapy drugs. It suggests that CypA might be considered as a kind of oncogene, which is expected to be a novel target for tumor treatment.

Key words: Neoplasms, Cyclophilin A, Molecular mechanisms of pharmacological action

陆凯强，周志刚，田雯，邹志楠，廖彩勤，谢飞燕，涂剑. 亲环素A在肿瘤中的作用机制[J]. 国际肿瘤学杂志, 2016, 43(6): 439-441.

Lu Kaiqiang, Zhou Zhigang, Tian Wen, Zou Zhinan, Liao Caiqin, Xie Feiyan, Tu Jian. Mechanism of Cyclophilin A in tumor[J]. Journal of International Oncology, 2016, 43(6): 439-441.

参考文献

［1］ Sun S, Wang Q, Giang A, et al. Knockdown of CypA inhibits interleukin，8 (IL，8) and IL8mediated proliferation and tumor growth of glioblastoma cells through downregulated NFκB［J］. J Neurooncol, 2011, 101(1): 1，14. DOI: 10.1007/s11060，010，0220，y. ［2］ Sun S, Guo M, Zhang JB, et al. Cyclophilin A (CypA) interacts with NFκB subunit, p65/RelA, and contributes to NFκB activation signaling［J］. PLoS One, 2014, 9(8): e96211. DOI: 10.1371/journal.pone. ［3］ Benarafa C. Tumorinduced inflammation alters neutrophil phenotype and disease progression［J］. Breast Cancer Res, 2015, 17(1): 135. DOI: 10.1186/s13058-015-0644-6. ［4］ Simon PS, Sharman SK, Lu C, et al. The NFκB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription［J］. BMC Cancer, 2015, 15: 770. DOI: 10.1186/s12885-015-1808-6. ［5］ Obchoei S, Sawanyawisuth K, Wongkham C, et al. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway［J］. Tumour Biol, 2015, 36(2): 849-859. DOI: 10.1007/s13277-014-2691-5. ［6］ Gelbert LM, Cai S, Lin X, et al. Preclinical characterization of the CDK4/6 inhibitor LY2835219: invivo cell cycledependent/independent antitumor activities alone/in combination with gemcitabine［J］. Invest New Drugs, 2014, 32(5): 825-837. DOI: 10.1007/s10637-014-0120-7. ［7］ Dong P, Maddali MV, Srimani JK, et al. Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control［J］. Nat Commun, 2014, 5: 475. DOI: 10.1038/ncomms5750. ［8］ Syed F, Rycyzyn MA, Westgate L, et al. A novel and functional interaction between cyclophilin A and prolactin receptor［J］. Endocrine, 2003, 20(12): 83-90. ［9］ Alkharusi A, Lesma E, Ancona S, et al. Role of prolactin receptors in lymphangioleiomyomatosis［J］. PLoS One, 2016, 11(1): e0146653. DOI: 10.1371/journal.pone.0146653. ［10］ Asher JM, O′Leary KA, Rugowski DE, et al. Prolactin promotes mammary pathogenesis independently from cyclinD1［J］. Am J Pathol, 2012, 181(1): 294302. DOI: 10.1016/j.ajpath.2012.03.041. ［11］ Tang Y, Lv P, Sun Z, et al. 1433β promotes migration and invasion of human hepatocellular carcinoma cells by modulating expression of MMP2 and MMP9 through PI3K/Akt/NFκB pathway［J］. PLoS One, 2016, 11(1): e0146070. DOI: 10.1371/journal.pone.0146070. ［12］ Takahashi M, Suzuki S, Ishikawa K. Cyclophilin AEMMPRIN interaction induces invasion of head and neck squamous cell carcinoma［J］. Oncol Rep, 2012, 27(1): 198203. DOI: 10.3892/or.2011.1474. ［13］ Xu T, Zhou M, Peng L, et al. Upregulation of CD147 promotes cell invasion, epithelialtomesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer［J］. Int J Clin Exp Pathol, 2014, 7(11): 7432-7441. ［14］ Gravina GL, Mancini A, Muzi P, et al. CXCR4 pharmacological inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models［J］. Prostate, 2015, 75(12): 1227-1246. DOI: 10.1002/pros.23007. ［15］张涓娟, 蒲宇, 李勇, 等. PI3K/AKT和MAPK/ERK1/2信号通路对胰腺癌PANC1细胞VEGF表达的影响［J］. 川北医学院学报, 2014, 29(1): 44-48. DOI: 10.3969/J.ISSN.1005-3697.2014.01.09. ［16］ Huang C, Sun Z, Sun Y, et al. Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma［J］. Histopathology, 2012, 60(5): 793803. DOI: 10.1111/j.13652559.2011.04130.x. ［17］ Li J, Peng L, Wu L, et al. Depletion of CD147 sensitizes human malignant melanoma cells to hydrogen peroxideinduced oxidative［J］. J Dermatol Sci, 2010, 58(3): 204-210. DOI: 10.1016/j.jdermsci.2010.03.022. ［18］ Kim H, Oh Y, Kim K, et al. Cyclophilin A regulates JNK/p38MAPK signaling through its physical interaction with ASK1［J］. Biochem Biophys Res Commun, 2015, 464(1): 112-117. DOI: 10.1016/j.bbrc.2015.06.078. ［19］ Jiang Q, Yuan Y, Zhou J, et al. Apoptotic events induced by high glucose in human hepatoma HepG2 cells involve endoplasmic reticulum stress and MAPK′s activation［J］. Mol Cell Biochem, 2015, 399(1-2): 113-122. DOI: 10.1007/s11010-014-2238-5. ［20］ Cheng YX, Liu R, Wang Q, et al. Realgarinduced apoptosis of cervical cancer cell line Siha via cytochrome c release andcaspase3 and caspase9 activation［J］. Chin J Integr Med, 2012, 18(5): 359-365. DOI: 10.1007/s11655-011-0697-z. ［21］刘凤华. CypA对胰腺癌生物学行为的影响及机制研究［D］. 天津: 天津医科大学, 2012. ［22］ Huang Q, Li J, Xing J, et al. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53dependent signaling pathway［J］. J Hepatol, 2014, 61(4): 859866. DOI: 10.1016/j.jhep.2014.04.035. ［23］ Han X, Yoon SH, Ding Y, et al. Cyclosporin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells［J］. Oncol Rep, 2010, 23(4): 1053-1062. ［24］ Hamilton G. Cyclophilin A as a target of cisplatin chemosensitizers［J］. Curr Cancer Drug Targets, 2014, 14(1): 46-58. ［25］ Xie ZY, Lv K, Xiong Y, et al. ABCG2meditated multidrug resistance and tumorinitiating capacity of side population cells from colon cancer［J］. Oncol Res Treat, 2014, 37(11): 666-668, 670-672. DOI: 10.1159/000368842.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.

亲环素A在肿瘤中的作用机制

Mechanism of Cyclophilin A in tumor

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价